Corcept Therapeutics Inc (NASDAQ: CORT) stock enjoyed a major increase of 13.6% on 1/30/25. The shares closed at $69.90. Moreover, exceptionally high trading volume at 224% of normal accompanied the advance. Relative to the market the stock has been exceptionally strong over the last nine months and has risen 18.4% during the last week.
Current PriceTarget Research Rating
Corcept Therapeutics has a current Value Trend Rating of C (Neutral). This rating combines very contradictory signals from two proprietary PTR measures of a stock’s attractiveness. Corcept Therapeutics has a poor Appreciation Score of 18 but a very high Power Rating of 93, triggering the Neutral Value Trend Rating.
Rating Review
In light of this very positive price change we are reviewing our current Overall Rating of C. This review will be completed in the next several days.
Be the first to comment